Transcat (NASDAQ:TRNS – Get Rating) had its price objective increased by research analysts at HC Wainwright from $77.00 to $85.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the scientific and technical instruments company’s stock. HC Wainwright’s price objective suggests a potential upside of 17.31% from the stock’s previous close.
A number of other brokerages have also weighed in on TRNS. Craig Hallum reduced their price objective on shares of Transcat from $94.00 to $81.00 and set a “buy” rating on the stock in a report on Wednesday, May 25th. Roth Capital reduced their price objective on shares of Transcat from $97.00 to $80.00 and set a “buy” rating on the stock in a report on Thursday, May 26th.
Transcat Stock Performance
Shares of TRNS stock opened at $72.46 on Wednesday. The company has a quick ratio of 1.70, a current ratio of 2.15 and a debt-to-equity ratio of 0.54. Transcat has a 52 week low of $50.32 and a 52 week high of $101.05. The stock has a market capitalization of $546.93 million, a PE ratio of 51.39 and a beta of 0.87. The firm has a 50 day moving average of $60.39 and a two-hundred day moving average of $71.17.
In other news, Director Carl E. Sassano sold 20,000 shares of the business’s stock in a transaction dated Thursday, May 26th. The stock was sold at an average price of $63.14, for a total value of $1,262,800.00. Following the completion of the sale, the director now directly owns 45,095 shares of the company’s stock, valued at approximately $2,847,298.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.80% of the company’s stock.
Institutional Trading of Transcat
Institutional investors and hedge funds have recently made changes to their positions in the company. US Bancorp DE lifted its holdings in shares of Transcat by 137.9% in the 1st quarter. US Bancorp DE now owns 345 shares of the scientific and technical instruments company’s stock valued at $28,000 after purchasing an additional 200 shares during the last quarter. Covestor Ltd purchased a new stake in shares of Transcat in the 4th quarter valued at about $44,000. Amalgamated Bank purchased a new stake in Transcat during the 1st quarter valued at approximately $94,000. Janney Montgomery Scott LLC purchased a new stake in Transcat during the 4th quarter valued at approximately $213,000. Finally, Advisor Group Holdings Inc. raised its stake in Transcat by 184.8% during the 4th quarter. Advisor Group Holdings Inc. now owns 2,612 shares of the scientific and technical instruments company’s stock valued at $241,000 after acquiring an additional 1,695 shares during the last quarter. 75.11% of the stock is owned by hedge funds and other institutional investors.
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
- Get a free copy of the StockNews.com research report on Transcat (TRNS)
- How Does Freeport McMoran Inc Compare to Its Sector Competitors?
- 3 Hotel Stocks to Consider Checking into After Earnings
- Can FuelCell Energy Surge Higher This Year?
- Is It Time to Take a Ride on Cedar Fair Stock?
- These Are The Top Insider Buying Stocks For July
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.